What were Shree Ganesh Remedies Ltd's latest quarterly results?
Shree Ganesh Remedies Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -4.9% (stable)
- Revenue Growth YoY: +35.9%
- Operating Margin: 34.3% (volatile)
Shree Ganesh Remedies Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +44.5%Average4w Streak
In , Shree Ganesh Remedies Ltd (Chemicals - Organic) is outperforming Nifty 500 with +44.5% relative strength. Fundamentals: Average. On a 4-week streak.
Shree Ganesh Remedies Ltd Key Facts
- PE Ratio
- 51.3x
- Market Cap
- ₹911 Cr
- PAT Growth YoY
- -5%
- Revenue Growth YoY
- +36%
- OPM
- 34.3%
- RS vs Nifty 500
- +44.5%
PE: Mid ExpansionFalling Knife
What's Happening
🔻Earnings declining and PE falling — fundamentals deteriorating
📊Debt increased 23% YoY — leverage rising
👔Promoter buying — stake up 2.3% this quarter
💰Trading 84% above estimated fair value — significant premium
Key Numbers
PAT Growth YoY
-5%
Stable
Revenue YoY
+36%
Inflection Up
Operating Margin
34.3%
-616 bps YoY
PE Ratio
51.3
Current Price
₹710
Fundamental Score
41/100
Average
3Y PAT CAGR
-20%
Market Cap
911 Cr
Valuation
Significantly Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Shree Ganesh Remedies Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +36% | -7% | Inflection Up |
| PAT (Net Profit) | -5% | -20% | Stable |
| OPM | 34.3% | -616 bps | Volatile |
Other Top Chemicals - Organic Stocks Beating Nifty 500
Frequently Asked Questions: Shree Ganesh Remedies Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Shree Ganesh Remedies Ltd's profit growing or declining?
Shree Ganesh Remedies Ltd's profit is declining with an stable trend.
- PAT Growth YoY: -4.9% (latest quarter)
- PAT Growth QoQ: +102.9% (sequential)
- 3-Year PAT CAGR: -19.8%
- Trend: Stable — consistent growth pattern
What is Shree Ganesh Remedies Ltd's revenue growth trend?
Shree Ganesh Remedies Ltd's revenue growth trend is turning around (inflection up).
- Revenue Growth YoY: +35.9%
- Revenue Growth QoQ: +57.3% (sequential)
- 3-Year Revenue CAGR: -7.0%
How is Shree Ganesh Remedies Ltd's operating margin trending?
Shree Ganesh Remedies Ltd's operating margin is volatile.
- Current OPM: 34.3%
- OPM Change YoY: -6.2% basis points
- OPM Change QoQ: +2.4% basis points
What is Shree Ganesh Remedies Ltd's 3-year profit and revenue CAGR?
Shree Ganesh Remedies Ltd's long-term compounding rates
- 3-Year Profit CAGR: -19.8%
- 3-Year Revenue CAGR: -7.0%
Is Shree Ganesh Remedies Ltd's growth accelerating or decelerating?
Shree Ganesh Remedies Ltd's earnings growth is stable with mixed signals on a sequential basis.
- YoY Acceleration: +38.1% bps
- Sequential Acceleration: +87.7% bps
- Margin Warning: Operating margins are under pressure
What is Shree Ganesh Remedies Ltd's trailing twelve month (TTM) performance?
Shree Ganesh Remedies Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹18 Cr
- TTM PAT Growth: -23.0% YoY
- TTM Revenue: ₹109 Cr
- TTM Revenue Growth: +0.7% YoY
- TTM Operating Margin: 32.0%
Is Shree Ganesh Remedies Ltd overvalued or undervalued?
Shree Ganesh Remedies Ltd appears significantly overvalued based on our fair value analysis.
- Valuation Signal: Significantly Overvalued
- Current PE: 51.3x
- Price-to-Book: 5.6x
What is Shree Ganesh Remedies Ltd's current PE ratio?
Shree Ganesh Remedies Ltd's current PE ratio is 51.3x.
- Current PE: 51.3x
- Market Cap: 911 Cr
How does Shree Ganesh Remedies Ltd's valuation compare to its history?
Shree Ganesh Remedies Ltd's current PE is 51.3x.
- Current PE: 51.3x
- Valuation Assessment: Significantly Overvalued
What is Shree Ganesh Remedies Ltd's price-to-book ratio?
Shree Ganesh Remedies Ltd's price-to-book ratio is 5.6x.
- Price-to-Book (P/B): 5.6x
- Book Value per Share: ₹127
- Current Price: ₹710
Is Shree Ganesh Remedies Ltd a fundamentally strong company?
Shree Ganesh Remedies Ltd is rated Average with a fundamental score of 41/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +35.9% (10% weight)
- PAT Growth YoY: -4.9% (10% weight)
- PAT Growth QoQ: +102.9% (10% weight)
- Margins stable (10% weight)
Is Shree Ganesh Remedies Ltd debt free?
Shree Ganesh Remedies Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹31 Cr
What is Shree Ganesh Remedies Ltd's return on equity (ROE) and ROCE?
Shree Ganesh Remedies Ltd's return ratios over recent years
- FY2025: ROCE 19.0%
- FY2026: ROCE 15.0%
Is Shree Ganesh Remedies Ltd's cash flow positive?
Shree Ganesh Remedies Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹0 Cr
- CFO/PAT Ratio: 0% (weak cash conversion)
What is Shree Ganesh Remedies Ltd's dividend yield?
Shree Ganesh Remedies Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹710
Who holds Shree Ganesh Remedies Ltd shares — promoters, FII, DII?
Shree Ganesh Remedies Ltd's shareholding pattern (Mar 2026)
- Promoters: 72.8%
- FII (Foreign): 0.0%
- Public: 27.2%
Is promoter holding increasing or decreasing in Shree Ganesh Remedies Ltd?
Shree Ganesh Remedies Ltd's promoter holding has increased recently.
- Current Promoter Holding: 72.8% (Mar 2026)
- Previous Quarter: 72.8% (Dec 2025)
- Change: +0.03% (increasing — positive signal)
How long has Shree Ganesh Remedies Ltd been outperforming Nifty 500?
Shree Ganesh Remedies Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.
Is Shree Ganesh Remedies Ltd a new momentum entry or an established outperformer?
Shree Ganesh Remedies Ltd is an established outperformer with 4 weeks of consecutive Nifty 500 outperformance.
Is Shree Ganesh Remedies Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Shree Ganesh Remedies Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Shree Ganesh Remedies Ltd?
Shree Ganesh Remedies Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +35.9% YoY
Risk Factors (Bear Case)
- Margins under pressure
- Appears significantly overvalued
What is the future outlook for Shree Ganesh Remedies Ltd?
Shree Ganesh Remedies Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: turning around (inflection up)
- Margin Trend: volatile
- Valuation: Significantly Overvalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.